Literature DB >> 16410556

When to test women for human papillomavirus.

Mark Schiffman, Philip E Castle.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16410556      PMCID： PMC1326915          DOI： 10.1136/bmj.332.7533.61

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Adding a test for human papillomavirus DNA to cervical-cancer screening.

Authors:  Thomas C Wright; Mark Schiffman
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

2.  Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study.

Authors:  Sue Moss; Alastair Gray; Rosa Legood; Martin Vessey; Julietta Patnick; Henry Kitchener
Journal:  BMJ       Date:  2006-01-06

3.  Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies.

Authors:  Rosa Legood; Alastair Gray; Jane Wolstenholme; Sue Moss
Journal:  BMJ       Date:  2006-01-06

4.  HPV testing in cervical cytology practice: it's all about choice.

Authors:  Mark H Stoler
Journal:  Acta Cytol       Date:  2005 Mar-Apr       Impact factor: 2.319

5.  Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.

Authors:  Lynette Denny; Louise Kuhn; Michelle De Souza; Amy E Pollack; William Dupree; Thomas C Wright
Journal:  JAMA       Date:  2005-11-02       Impact factor: 56.272

Review 6.  Statistical issues in human papillomavirus testing and screening.

Authors:  E L Franco
Journal:  Clin Lab Med       Date:  2000-06       Impact factor: 1.935

7.  Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.

Authors:  Philip E Castle; Diane Solomon; Mark Schiffman; Cosette M Wheeler
Journal:  J Natl Cancer Inst       Date:  2005-07-20       Impact factor: 13.506

8.  Management of women who test positive for high-risk types of human papillomavirus: the HART study.

Authors:  J Cuzick; A Szarewski; H Cubie; G Hulman; H Kitchener; D Luesley; E McGoogan; U Menon; G Terry; R Edwards; C Brooks; M Desai; C Gie; L Ho; I Jacobs; C Pickles; P Sasieni
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

9.  Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students.

Authors:  Rachel L Winer; Shu-Kuang Lee; James P Hughes; Diane E Adam; Nancy B Kiviat; Laura A Koutsky
Journal:  Am J Epidemiol       Date:  2003-02-01       Impact factor: 4.897

10.  Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study.

Authors:  Richard Guido; Mark Schiffman; Diane Solomon; Louis Burke
Journal:  Am J Obstet Gynecol       Date:  2003-06       Impact factor: 8.661
View more
  1 in total

1.  Asian society of gynecologic oncology workshop 2010.

Authors:  Dong Hoon Suh; Jae Weon Kim; Mohamad Farid Aziz; Uma K Devi; Hextan Y S Ngan; Joo-Hyun Nam; Seung Cheol Kim; Tomoyasu Kato; Hee Sug Ryu; Shingo Fujii; Yoon Soon Lee; Jong Hyeok Kim; Tae-Joong Kim; Young Tae Kim; Kung-Liahng Wang; Taek Sang Lee; Kimio Ushijima; Sang-Goo Shin; Yin Nin Chia; Sarikapan Wilailak; Sang Yoon Park; Hidetaka Katabuchi; Toshiharu Kamura; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.